News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Nash Christine A
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/19/2023 |
4
| Nash Christine A (Director) has filed a Form 4 on Rallybio Corp|
Txns:
| Granted 15,490 options to buy
@ $5.64, valued at
$87.4k
|
|
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/06/2022 |
4
| Nash Christine A (Director) has filed a Form 4 on Rallybio Corp|
Txns:
| Granted 26,880 options to buy
@ $8.22, valued at
$221k
|
|
| 04/06/2022 |
3
| Nash Christine A (Director) has filed a Form 3 on Rallybio Corp |
| 05/08/2015 |
4
| Nash Christine A (SVP & Chief Commercial Officer) has filed a Form 4 on HYPERION THERAPEUTICS INC|
Txns:
| Unknown transaction of 11,503 shares
@ $46, valued at
$529.1k
Disposed/sold 25,500 shares
@ $46, valued at
$1.2M
Disposed/sold 59,087 shares
@ $46, valued at
$2.7M
Disposed/sold 6,881 options to buy
@ $7.31, valued at
$50.3k
Disposed/sold 39,500 options to buy
@ $24.46, valued at
$966.2k
Disposed/sold 50,000 options to buy
@ $26.74, valued at
$1.3M
Disposed/sold 32,500 options to buy
@ $25.97, valued at
$844k
Disposed/sold 91 options to buy
@ $327.95, valued at
$29.8k
Disposed/sold 18 options to buy
@ $327.95, valued at
$5.9k
|
|
| 05/05/2015 |
4
| Nash Christine A (SVP & Chief Commercial Officer) has filed a Form 4 on HYPERION THERAPEUTICS INC|
Txns:
| Exercised 16,157 options to buy
@ $1.28, valued at
$20.7k
Exercised 12,709 options to buy
@ $4.08, valued at
$51.9k
Exercised 30,221 options to buy
@ $7.31, valued at
$220.9k
|
|
| 03/17/2015 |
4
| Nash Christine A (SVP & Chief Commercial Officer) has filed a Form 4 on HYPERION THERAPEUTICS INC|
Txns:
| Sold 10,000 shares
@ $37.56, valued at
$375.6k
Exercised 10,000 options to buy
@ $4.08, valued at
$40.8k
|
|
| 03/13/2015 |
4
| Nash Christine A (SVP & Chief Commercial Officer) has filed a Form 4 on HYPERION THERAPEUTICS INC|
Txns:
| Exercised 10,000 shares
@ $4.08, valued at
$40.8k
Sold 10,000 shares
@ $35.08, valued at
$350.8k
Exercised 10,000 options to buy
@ $4.08, valued at
$40.8k
|
|
| 03/10/2015 |
4
| Nash Christine A (SVP & Chief Commercial Officer) has filed a Form 4 on HYPERION THERAPEUTICS INC|
Txns:
| Sold 5,650 shares
@ $29.32, valued at
$165.7k
Sold 2,800 shares
@ $30, valued at
$84k
Sold 1,450 shares
@ $30.1, valued at
$43.6k
|
|
| 02/10/2015 |
4
| Nash Christine A (SVP & Chief Commercial Officer) has filed a Form 4 on HYPERION THERAPEUTICS INC|
Txns:
| Granted 18,000 shares
@ $0
Granted 32,500 options to buy
@ $25.97, valued at
$844k
|
|
| 01/22/2015 |
4
| Nash Christine A (SVP & Chief Commercial Officer) has filed a Form 4 on HYPERION THERAPEUTICS INC|
Txns:
| Sold 2,500 shares
@ $24.36, valued at
$60.9k
Sold 2,500 shares
@ $25.27, valued at
$63.2k
|
|
| 01/05/2015 |
4
| Nash Christine A (SVP & Chief Commercial Officer) has filed a Form 4 on HYPERION THERAPEUTICS INC|
Txns:
| Paid exercise price by delivering 1,095 shares
@ $24.28, valued at
$26.6k
|
|
| 10/17/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/13/2014 |
4
| Nash Christine A (SVP & Chief Commercial Officer) has filed a Form 4 on HYPERION THERAPEUTICS INC|
Txns:
| Granted 10,000 shares
@ $0
Granted 50,000 options to buy
@ $26.74, valued at
$1.3M
|
|
| 03/10/2014 |
4
| Nash Christine A (SVP & Chief Commercial Officer) has filed a Form 4 on HYPERION THERAPEUTICS INC|
Txns:
| Sold 5,000 shares
@ $29.026, valued at
$145.1k
Sold 100 shares
@ $30.05, valued at
$3k
Exercised 15,000 options to buy
@ $1.28, valued at
$19.2k
|
|
| 01/14/2014 |
4
| Nash Christine A (SVP & Chief Commercial Officer) has filed a Form 4 on HYPERION THERAPEUTICS INC|
Txns:
| Sold 8,900 shares
@ $24.0999, valued at
$214.5k
Sold 1,100 shares
@ $24.0108, valued at
$26.4k
Exercised 8,900 options to buy
@ $1.28, valued at
$11.4k
Exercised 6,100 options to buy
@ $1.28, valued at
$7.8k
|
|
| 05/01/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/02/2012 |
4
| Nash Christine A (SVP & Chief Commercial Officer) has filed a Form 4 on HYPERION THERAPEUTICS INC|
Txns:
| Converted 97 shares
@ $0
Converted 97 preferred shares
@ $0 |
|
| 07/25/2012 |
3
| Nash Christine A (SVP & Chief Commercial Officer) has filed a Form 3 on HYPERION THERAPEUTICS INC |
|
|